Dextromethorphan/QuinidineIn Pseudobulbar Affect

被引：0
作者：
Karly P. Garnock-Jones
机构：
[1] a Wolters Kluwer Business,Adis
来源：
CNS Drugs | 2011年 / 25卷
关键词：
Multiple Sclerosis; Amyotrophic Lateral Sclerosis; Placebo Recipient; Quinidine; Memantine;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
Pseudobulbar affect is characterized by uncontrollable, inappropriate laughing and/or crying that is either unrelated or out of proportion to the emotions felt by the patient and occurs in patients with neurological disorders, such as amyotrophic lateral sclerosis (ALS), multiple sclerosis or traumatic brain injury.
引用
收藏
页码：435 / 445
页数：10
相关论文
共 49 条
[1]  
Rosen HJ(2007)A real reason for patients with pseudobulbar affect to smile Ann Neurol 61 92-6
[2]  
Cummings J(2006)Pseudobulbar affect in multiple sclerosis: toward the development of innovative therapeutic strategies J Neurol Sci 245 153-9
[3]  
Miller A(2008)Pathological laughing and crying: epidemiology, pathophysiology and treatment CNS Drugs 22 531-45
[4]  
Wortzel HS(2007)It’s nothing to laugh about: understanding disorders of emotional expression Consult Pharm 22 732-42
[5]  
Oster TJ(2010)Pseudobulbar affect: prevalence and quality of life impact in movement disorders J Neurol 257 1382-7
[6]  
Anderson CA(2007)Pathophysiology of involuntary emotional expression disorder CNS Spectr 12 17-22
[7]  
Martin CM(2006)Randomized, controlled trial of dextromethorphan/quinidine for pseudobulbar affect in multiple sclerosis Ann Neurol 59 780-7
[8]  
Strowd RE(2004)Treatment of pseudobulbar affect in ALS with dextromethorphan/ quinidine: a randomized trial Neurology 63 1364-70
[9]  
Cartwright MS(2010)Dextromethorphan plus ultra low-dose quinidine reduces pseudobulbar affect Ann Neurol 68 693-702
[10]  
Okun MS(2009)Effects of dextromethorphan/ quinidine on auditory event-related potentials in multiple sclerosis patients with pseudobulbar affect J Clin Psychopharmacol 29 444-52
12345